• English
  • Español
  • CONTACT US
  • HOME
ONCOMATRYX

ONCOMATRYX

pioneering stromal medicine

Menu

  • ABOUT
    • TARGETING TUMOR STROMA
    • LEADERSHIP
    • SCIENTIFIC ADVISORY BOARD
    • COLLABORATIONS
    • PUBLICATIONS
  • DRUG DISCOVERY
    • PRECISION DRUGS
    • ANTIBODY DRUG CONJUGATES
      • ADC OMTX705
      • ADC OMTX703
    • PIPELINE
  • DIAGNOSTICS
    • COL11A1 BIOMARKER
    • INVASIVE TUMOR DIAGNOSTICS -invaScan-
    • BLADDER CANCER DIAGNOSTICS -bladderScan-
  • COMPANION DX
    • COMPANION DIAGNOSTICS
  • BLOG
    • TEAM POSTS
    • NEWS
    • PRESS Releases
    • VIDEO
  • CONTACT
    • CONTACT US
    • CAREERS
    • NEXT EVENT

Month: January 2013

New treatments against the most invasive cancer

New treatments against the most invasive cancer

Publisehed by El Dato Magazine el 2013-01-01 New treatments against the most invasive cancer Develops in collaboration with renowned public and private national and foreign companies, new drugs that help to

Oncomatryx2013-01-012019-07-09 PRESS Releases No Comments Read more

Archives

  • May 2022
  • March 2022
  • November 2020
  • October 2018
  • February 2018
  • April 2017
  • February 2017
  • November 2016
  • September 2016
  • August 2016
  • April 2016
  • February 2016
  • December 2015
  • July 2015
  • May 2015
  • June 2013
  • January 2013

Meta

  • Log in

PRECISION DRUGS

  • PRECISION DRUGS
  • ANTIBODY DRUG CONJUGATES
  • PIPELINE

DIAGNOSTICS

  • COL11A1 BIOMARKER
  • INVASIVE TUMOR DIAGNOSTICS -invaScan-
  • BLADDER CANCER DIAGNOSTICS -bladderScan-

With the collaboration of:

ONCOMATRYX BIOPHARMA SL ©2019
  • English
  • Español
  • TERMS OF USE
  • PRIVACY POLICY
  • SITE MAP